Study of SCY-078 in patients with in patients with refractory invasive fungal infections
Latest Information Update: 10 Aug 2016
At a glance
- Drugs Ibrexafungerp (Primary) ; Ibrexafungerp (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 10 Aug 2016 New trial record
- 01 Aug 2016 According to Scynexis media release, this trial is expected to start by the end of 2016.